πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,756 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6309854

Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72

The Board of Regents of the University of Texas System Β· Granted Tue Oct 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6309644

Parasitic nematode transglutaminase proteins and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Oct 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6300308

Methods and compositions for inducing autoimmunity in the treatment of cancers

The Board of Regents of the University of Texas System Β· Granted Tue Oct 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6300101

Methods and compositions including a 13kD B. burgdorferi protein

The Board of Regents of the University of Texas System Β· Granted Tue Oct 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6296849

Methods and compositions including a 13kDa B. burgdorferi protein

The Board of Regents of the University of Texas System Β· Granted Tue Oct 02 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6294650

Inhibition of mammalian telomerase by peptide nucleic acids

The Board of Regents of the University of Texas System Β· Granted Tue Sep 25 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6287607

Potassium calcium citrate compositions and methods therefor

The Board of Regents of the University of Texas System Β· Granted Tue Sep 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6280958

Rh blood group antigen compositions and methods of use

The Board of Regents of the University of Texas System Β· Granted Tue Aug 28 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6277375

Immunoglobulin-like domains with increased half-lives

The Board of Regents of the University of Texas System Β· Granted Tue Aug 21 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6271207

Enhanced expression of transgenes

The Board of Regents of the University of Texas System Β· Granted Tue Aug 07 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6271201

Methods for the selective regulation of placental prostanoids and inhibition of labor usin

The Board of Regents of the University of Texas System Β· Granted Tue Aug 07 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6265214

Methods and compositions for inducing monocyte cytotoxicity

The Board of Regents of the University of Texas System Β· Granted Tue Jul 24 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6262257

Calixpyrroles, calixpyridinopyrroles and calixpyridines

The Board of Regents of the University of Texas System Β· Granted Tue Jul 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6262242

Tumor suppressor designated TS10Q23.3

The Board of Regents of the University of Texas System Β· Granted Tue Jul 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6258870

Gels for encapsulation of biological materials

The Board of Regents of the University of Texas System Β· Granted Tue Jul 10 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6251878

Inhibition of UV-induced immune suppression and interleukin-10 production by cytoprotectiv

The Board of Regents of the University of Texas System Β· Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6251871

P16 expression constructs and their application in cancer therapy

The Board of Regents of the University of Texas System Β· Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6248351

Human PEA3 is a tumor suppressor for cancer cells

The Board of Regents of the University of Texas System Β· Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6242418

Therapeutic uses of BPI protein products for human meningococcemia

The Board of Regents of the University of Texas System Β· Granted Tue Jun 05 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6231892

Compositions for coating microcapsules and other surfaces

The Board of Regents of the University of Texas System Β· Granted Tue May 15 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6210873

Methods and compositions for the priming of specific cytotoxic T-lymphocyte response

The Board of Regents of the University of Texas System Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6207690

Troglitazone compounds for treating climacteric and cancer

The Board of Regents of the University of Texas System Β· Granted Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6203793

Compositions and methods for treating thermal injury

The Board of Regents of the University of Texas System Β· Granted Tue Mar 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6201165

Transgenic animal models for cardiac hypertrophy and methods of use thereof

The Board of Regents of the University of Texas System Β· Granted Tue Mar 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired